BOSTON BLEEDING DISORDERS CENTER
Live / Registered — Registered (as of 07 Oct 2025)
What this means for you
Registered since 07 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98922974
- Registration number
- 7978404
- Mark type
- Stylized text
- Filed
- 26 Dec 2024
- Registered
- 07 Oct 2025
- Attorney of record
- Aaron Y. Silverstein
Goods and services
- Class 042 — Scientific and technological services: Medical research; Medical and scientific research information in the fields of health care and blood disorders; Scientific research in the field of blood disorders; Scientific research; Medical and scientific research, namely, conducting clinical trials for others; Medical research in the field of blood disorders; Research and development in the fields of medicine and blood disorders
- Class 044 — Medical, beauty and agricultural services: Providing health information; Health care in the field of blood disorders; Hospital services; Physical rehabilitation; Consulting services in the field of medical care and blood disorders; Medical services; Medical services in the field of blood disorders; Health care
Owner
- The Brigham and Women's Hospital, Inc., Boston, MA, US
- The Brigham and Women's Hospital, Inc., Boston, MA, US
Prosecution history
- 07 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Oct 2025 — REGISTERED-SUPPLEMENTAL REGISTER
- 05 Sept 2025 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 04 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Aug 2025 — NON-FINAL ACTION E-MAILED
- 12 Aug 2025 — NON-FINAL ACTION WRITTEN
- 14 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Jun 2025 — NON-FINAL ACTION E-MAILED
- 13 Jun 2025 — NON-FINAL ACTION WRITTEN